Sporadic aluminum osteomalacia: identification of patients at risk.
Chronic dialysis patients at risk for aluminum osteomalacia in areas of low water-aluminum content are not well identified. We, therefore, studied retrospectively a cohort of 59 patients who underwent bone biopsy at two hospital-based dialysis centers in Montreal (water aluminum content less than 10 micrograms/L). Overall, 25% of patients biopsied had aluminum-related osteomalacia defined by aluminum staining of more than 30% of the trabecular surface and low levels of bone formation as measured by tetracycline labeling. Multiple linear regression analysis showed high predialysis serum creatinine (P less than .05) and the amount of aluminum prescribed per month (P less than .05) as the most important determinants of aluminum staining. We conclude that aluminum-related osteomalacia can be a frequent disease entity in areas of low water-aluminum content. Our findings also suggest predialysis serum creatinine and the amount of aluminum prescribed per month are risk factors for the development of aluminum-related osteomalacia. Though the relationship between serum creatinine and aluminum staining of trabecular bone is unclear, serum creatinine is probably a marker for adequacy of dialysis in these patients.
Turner
M W
MW
Department of Medicine, Royal Victoria Hospital, Montreal, P. Quebec, Canada.
Ardila
M
M
Hutchinson
T
T
Prichard
S
S
Barré
P E
PE
Beauvais
J
J
Kaye
M
M
D000535:Aluminum / Q000009:adverse effects*; D001706:Biopsy; D001842:Bone and Bones / Q000473:pathology; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010018:Osteomalacia / Q000139:chemically induced* / Q000473:pathology; D011792:Quebec; D006435:Renal Dialysis; D012189:Retrospective Studies; D012307:Risk Factors; D014881:Water Supply
D000535:Aluminum